Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 158-161

  João, Cristina ^a,b,c  

^a MAYO CLINIC   (United States)

^b INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; PEPTIDE; T LYMPHOCYTE RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN FUNCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CANCER; CANCER CHEMOTHERAPY; CELL ACTIVATION; CELL COMPARTMENTALIZATION; CELL FUNCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; MODULATION; PRIORITY JOURNAL; T LYMPHOCYTE;

CYTOMEGALOVIRUS; FUNGI;

EID: 33750738300     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.05.062     Document Type: Article

References (26)

1. Arstila T.P.C.A., Casrouge A., Baron V., et al. A direct estimate of the human ab T cell receptor diversity. Science 286 (1999) 958-961
2. Silins S.L., Sherritt M.A., Silleri J.M., et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 98 13 (2001) 3739-3744
3. Okamoto R., Yamamoto K., Yabushita K., et al. T cell repertoire in primary biliary cirrhosis: a common T cell clone and repertoire change after treatment. J Clin Immunol 21 4 (2001) 278-285
4. Clemente C., Rao S., Lupetti R., et al. Immunohistochemical analysis of the T-cell receptor beta-chain variable regions expressed by T lymphocytes infiltrating primary human melanoma. Lab Invest 78 5 (1998) 619-627
5. Spits H. Development of alphabeta T cells in the human thymus. Nature Rev Immunol 2 10 (2002) 760-772
6. Surh C.D., Lee D.S., Fung-Leung W.P., Karlsson L., and Sprent J. Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. Immunity 7 2 (1997) 209-219
7. Barton G.M., and Rudensky A.Y. Requirement for diverse, low-abundance peptides in positive selection of T cells. Science 283 5398 (1999) 67-70
8. Joao C., Ogle B.M., Gay-Rabinstein C., Platt J.L., and Cascalho M. B cell-dependent TCR diversification. J Immunol 172 8 (2004) 4709-4716
9. Joao C., Ogle B.M., and Geyer S. Immunoglobulin promotes the diversity and the function of T cells. Eur J Immunol 36 (2006) 1718-1728
10. Freitas A.A., Viale A.C., Sundblad A., Heusser C., and Coutinho A. Normal serum immunoglobulins participate in the selection of peripheral B-cell repertoires. Proceedings of the national academy of sciences of the United States of America 88 13 (1991) 5640-5644
11. Dietrich G., Varela F.J., Hurez V., Bouanani M., and Kazatchkine M.D. Selection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis. Eur J Immunol 23 11 (1993) 2945-2950
12. Freitas A.A., and Rocha B. Lymphocyte survival: a red queen hypothesis. see comment. Science 277 5334 (1997) 1950
13. Benoist C., and Mathis D. Selection for survival?. comment. Science 276 5321 (1997) 2000-2001
14. Sullivan K.M., Kopecky K.J., Jocom J., et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. see comment. New Engl J Med 323 11 (1990) 705-712
15. Winston D.J., Ho W.G., Lin C.H., et al. Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med 106 1 (1987) 12-18
16. Bass E.B., Powe N.R., Goodman S.N., et al. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis. Bone Marrow Transpl 12 3 (1993) 273-282
17. Ogle B.M., Cascalho M., Joao C., Taylor W., West L.J., and Platt J.L. Direct measurement of lymphocyte receptor diversity. Nucleic Acids Res 31 22 (2003) e139
18. Horowitz M. New IBMTR/ABMTR slides summarize current use and outcome of allogeneic and autologous transplants. IBMTR News Lett [online]. Spring 7 (2000) 3-10
19. Porrata L.F., Gertz M.A., Inwards D.J., et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood 98 3 (2001) 579-585
20. Joao C., Porrata L.F., Inwards D.J., Ansell S.M., Micallef I.N., et al. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in Mantle Cell Lymphoma. Bone Marrow Transpl 37 (2006) 865-871
21. Porrata L.F., and Markovic S.N. Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation. Clin Exp Med 4 2 (2004) 78-85
22. Guillaume T., Rubinstein D.B., and Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92 5 (1998) 1471-1490
23. Mackall C.L., Fleisher T.A., Brown M.R., et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. see comment. New Engl J Med 332 3 (1995) 143-149
24. Stiehm E.R. Human intravenous immunoglobulin in primary and secondary antibody deficiencies. Pediatr Infect Dis J 16 7 (1997) 696-707
25. Kazatchkine M.D., and Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. New Engl J Med 345 10 (2001) 747-755
26. Hemming V. Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases. Clin Diagn Lab Immunol 8 (2001) 859-863